中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients

文献类型:期刊论文

作者Mu, Xin1; Huang, Ou2; Jiang, Min3; Xie, Zuoquan4; Chen, Debo5; Zhang, Xi5
刊名ONCOLOGY LETTERS
出版日期2019-05-17
卷号18期号:1页码:742-750
关键词breast cancer ephrin B receptors prognosis Kaplan-Meier plotter hazard ratio
ISSN号1792-1074
DOI10.3892/ol.2019.10363
文献子类Article
英文摘要The roles of Ephrin B (EphB) receptors in cancer are relatively unknown as these receptors are associated with complex signaling pathways. A limited number of studies have investigated the association between EphB receptors and prognosis. Using the Kaplan-Meier plotter database, the present study investigated the associations between the mRNA expression levels of five EphB receptors and the outcomes of 3,554 patients with breast cancer who had been followed-up for 20 years. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated to assess the relative risk of survival. The results demonstrated that high mRNA expression levels of EphB2 (HR, 0.74; 95% CI, 0.66-0.84; P=2.1x10-6), EphB4 (HR, 0.82; 95% CI, 0.72-0.93; P=0.0023) and EphB6 (HR, 0.69; 95% CI, 0.61-0.78; P=3x10-9) were significantly associated with improved survival, while a high mRNA expression level of EphB3 (HR, 1.14; 95% CI, 1.01-1.28; P=0.029) was associated with worse survival for patients with breast cancer. High expression levels of all EphB receptors, including EphB1 (HR, 1.4; 95% CI, 1.02-1.94; P=0.039), EphB2 (HR, 1.34; 95% CI, 1.07-1.67; P=0.011), EphB3 (HR, 1.39; 95% CI, 1.11-1.73, P=0.0038), EphB4 (HR, 1.33; 95% CI, 1.06-1.67; P=0.013) and EphB6 (HR, 1.32; 95% CI, 1.05-1.65; P=0.016), were associated with an increased risk of mortality in patients with lymph-node-positive breast cancer. High mRNA expression levels of EphB1 were not associated with survival for all patients with breast cancer (HR, 0.85; 95% CI, 0.72-1.01; P=0.058). The results of the present suggested that EphB receptors may be useful as prognostic biomarkers of breast cancer.
WOS关键词TYROSINE KINASE ; EPHB4 RECEPTOR ; CELL-MIGRATION ; EXPRESSION ; ACTIVATION ; GROWTH ; PROLIFERATION ; MODULATION ; MECHANISMS ; INHIBITION
WOS研究方向Oncology
语种英语
WOS记录号WOS:000474896900086
出版者SPANDIDOS PUBL LTD
源URL[http://119.78.100.183/handle/2S10ELR8/309428]  
专题新药研究国家重点实验室
通讯作者Zhang, Xi
作者单位1.Fujian Med Univ, Affiliated Hosp 2, Dept Urol, Quanzhou 362000, Fujian, Peoples R China;
2.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200025, Peoples R China;
3.Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou 215000, Jiangsu, Peoples R China;
4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200025, Peoples R China;
5.Fujian Med Univ, Hosp Quanzhou 1, Dept Breast Oncol, Anji Rd, Quanzhou 362000, Fujian, Peoples R China
推荐引用方式
GB/T 7714
Mu, Xin,Huang, Ou,Jiang, Min,et al. Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients[J]. ONCOLOGY LETTERS,2019,18(1):742-750.
APA Mu, Xin,Huang, Ou,Jiang, Min,Xie, Zuoquan,Chen, Debo,&Zhang, Xi.(2019).Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients.ONCOLOGY LETTERS,18(1),742-750.
MLA Mu, Xin,et al."Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients".ONCOLOGY LETTERS 18.1(2019):742-750.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。